Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Cognetivity Neurosciences Ltd    CGN   CA19243C1005

COGNETIVITY NEUROSCIENCES LTD

(CGN)
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Cognetivity Neurosciences : Arranges Convertible Notes

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 06:30pm EDT

VANCOUVER, Aug. 14, 2019 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN; FWB:1UB; OTCQB: CGNSF) announced that the Company has entered into convertible loan agreements with certain lenders and issued convertible notes (the "Notes") in the aggregate principal amount of up to $168,000

The Notes bearing interest at 8% per annum, matures 12 months from the date of issuance (the "Maturity Date").  At any time prior to the Maturity Date on at least 10 days prior written notice to the Company, the lender may, in its sole discretion, elect to convert all, but not less than all, of the principal amount, all accrued and unpaid interest and all other amounts due by the Company to the lender pursuant to the Note (the "Indebtedness") into a number of units of the Company (the "Units") equal to the quotient of the Indebtedness and $0.26.  Each Unit will be comprised of one common share of the Company (a "Share") and one share purchase warrant (a "Warrant") of the Company.  Each Warrant entitles the holder thereof to acquire one Share at $0.30 per Share for two years.

The Notes and all securities issued in connection with the Notes will be subject to a statutory hold period of four months and a day from the date of issuance in accordance with applicable securities law.

About Cognetivity Neurosciences Ltd.

Cognetivity is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical, commercial and consumer  environments.  Cognetivity's  ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of  the  brain,  potentially  allowing  early diagnosis of dementia. Cognetivity aims to develop the ICA through ongoing clinical studies to the market in North America, Europe and elsewhere in the world.

For more information please visit – www.cognetivity.com

ON BEHALF OF THE BOARD
"Sina Habibi"                                                          

Sina Habibi
Chief Executive Officer and Director

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release

SOURCE Cognetivity Neurosciences Ltd

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COGNETIVITY NEUROSCIENCES
08/14COGNETIVITY NEUROSCIENCES : Arranges Convertible Notes
AQ
08/13COGNETIVITY NEUROSCIENCES : Receives Key Chinese Patent Approval for its Proprie..
AQ
07/16COGNETIVITY NEUROSCIENCES' : Chief Medical Officer to Present at Alzheimer's Ass..
AQ
05/21COGNETIVITY NEUROSCIENCES : Selected to Present Groundbreaking New Research Data..
AQ
05/02COGNETIVITY NEUROSCIENCES : Appoints Digital Health Specialist to Drive Platform..
AQ
03/27COGNETIVITY NEUROSCIENCES : Selected to Present New Landmark Research Data at th..
AQ
03/19COGNETIVITY NEUROSCIENCES : Closes First Tranche of Non-Brokered Private Placeme..
AQ
03/13COGNETIVITY NEUROSCIENCES : Secures Critical Quality Standard Certification
AQ
02/11COGNETIVITY NEUROSCIENCES : Announces Non-Brokered Private Placement
AQ
01/31COGNETIVITY NEUROSCIENCES : Publishes Key Results From its Integrated Cognitive ..
AQ
More news
Chart COGNETIVITY NEUROSCIENCES LTD
Duration : Period :
Cognetivity Neurosciences Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Ravinder Singh Kang Director
David Velisek Director
Sector and Competitors
1st jan.Capitalization (M$)
COGNETIVITY NEUROSCIENCES LTD-52.78%6
VEEVA SYSTEMS INC77.00%23 283
ALIBABA HLTH INFRMTN TCHNLGY LTD5.35%10 252
OMNICELL, INC.15.12%2 948
B-SOFT CO LTD--.--%1 591
ALLSCRIPTS HEALTHCARE SOLUTIONS INC-5.71%1 515